EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering

Katja Glinšek, Krištof Bozovičar iD, Tomaž Bratkovič iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24098144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Katja Glinšek und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Clustered Regularly Interspaced Short Palindromic Repeats. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Slovenian Research Agency (ARRS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Chinese hamster ovary (CHO) cell line is a well-established platform for the production of biopharmaceuticals due to its ability to express complex therapeutic proteins with human-like glycopatterns in high amounts. The advent of CRISPR technology has opened up new avenues for the engineering of CHO cell lines for improved protein production and enhanced product quality. This review summarizes recent advances in the application of CRISPR technology for CHO cell line engineering with a particular focus on glycosylation modulation, productivity enhancement, tackling adventitious agents, elimination of problematic host cell proteins, development of antibiotic-free selection systems, site-specific transgene integration, and CRISPR-mediated gene activation and repression. The review highlights the potential of CRISPR technology in CHO cell line genome editing and epigenetic engineering for the more efficient and cost-effective development of biopharmaceuticals while ensuring the safety and quality of the final product.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsClustered Regularly Interspaced Short Palindromic RepeatsCricetinaeAnimalsHumansCricetulusCHO CellsTechnologyRecombinant Proteins

Stichwörter der Autor:innen

CRISPR-CasChinese hamster ovary cellsaugmenting productivitycell line developmentgenome editingglycoengineering

Substanzen

Recombinant Proteins

Autor:innen und Institutionen

  • Faculty of Pharmacy, University of Ljubljana, Aškerčeva 7, 1000 Ljubljana, Slovenia.

ORCID-Profile: Krištof Bozovičar, Tomaž Bratkovič

Förderung

  • Slovenian Research Agency (ARRS)

Zitieren

APA

Glinšek, K., Bozovičar, K., & Bratkovič, T. (2023). CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24098144

Vancouver

Glinšek K, Bozovičar K, Bratkovič T. CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24098144

BibTeX
@article{Glinek2023,
  author = {Glinšek, Katja and Bozovičar, Krištof and Bratkovič, Tomaž},
  title = {CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24098144}
}
Kostenlos starten →